Neoadjuvant Therapy in Resectable Pancreatic Cancer: Immortal Time Bias and Its Correction
J Clin Oncol
.
2017 May 10;35(14):1623.
doi: 10.1200/JCO.2016.71.2273.
Epub 2017 Jan 30.
Authors
Tzu-Yu Lai
1
,
Yu-Wen Hu
1
Affiliation
1
Tzu-Yu Lai, Taipei Veterans General Hospital, Taipei, Taiwan; and Yu-Wen Hu, Taipei Veterans General Hospital and Institute of Public Health, National Yang-Ming University, Taipei, Taiwan.
PMID:
28135147
DOI:
10.1200/JCO.2016.71.2273
No abstract available
Publication types
Letter
Comment
MeSH terms
Bias
Humans
Neoadjuvant Therapy*
Pancreatic Neoplasms*
Propensity Score